Physician profile
Deepu Raphael Thoppil
NPI 1154580249
$852.22
in general payments reported to CMS, 2019-2025
16 companies · $77.35 in 2025
The $77.35 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $395 · 2021: $83.49 · 2022: $27.60 · 2023: $20.88 · 2024: $58.21 · 2025: $77.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $254.51 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $73.97 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $67.39 | 2020-2021 | |
| Abbvie INC. | $65.89 | 2024-2025 | |
| Allergan, INC. | $59.16 | 2019 | |
| Mallinckrodt Enterprises LLC | $58.10 | 2019 | |
| Lilly USA, LLC | $43.47 | 2020-2023 | Mounjaro |
| Grifols USA, LLC | $43.17 | 2020 | |
| Mallinckrodt Hospital Products INC. | $33.00 | 2020 | |
| Amarin Pharma, INC. | $31.91 | 2019-2020 | |
| Exact Sciences Corporation | $31.17 | 2025 | The Cologuard Plus Collection Kit |
| Biomerieux INC | $21.08 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $20.20 | 2025 | |
| Novo Nordisk INC | $18.30 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.94 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $14.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepu Thoppil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.